There are no established biomarkers for BPC-157 response
Comparing peptide therapy, NAD+ therapy, and combined approaches Peptide therapy typically targets precise biological pathways to address healing, inflammation, or hormone signaling
Today, however, it has also been proven that in sufficient doses, oral supplements are just as effective as injections
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
Theyre for patients with very low levels of vitamin B12 or certain health issues
Deviated septum surgery: reported minimal scarring and swelling resolving in weeks rather than months
